Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, et al. Model-based drug development. Clin Pharmacol & Ther. 2007;82(1):21–32.

Article  CAS  Google Scholar 

Milligan PA, Brown MJ, Marchant B, Martin SW, Van Der Graaf PH, Benson N, et al. Model-based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol & Ther. 2013;93(6):502–14.

Article  CAS  Google Scholar 

Jaiswal S, Ahmed T, Kollipara S, Bhargava M, Chachad S. Development, validation and application of physiologically based biopharmaceutics model to justify the change in dissolution specifications for DRL ABC extended release tablets. Drug Dev Ind Pharm. 2021;47(5):778–89.

Article  CAS  PubMed  Google Scholar 

Wu D, Sanghavi M, Kollipara S, Ahmed T, Saini AK, Heimbach T. Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs. Pharm Res. 2023;40(2):337–57.

Article  CAS  PubMed  Google Scholar 

Zhao L, Kim M-J, Zhang L, Lionberger R. Generating model integrated evidence for generic drug development and assessment. Clin Pharmacol Ther. 2019;105(2):338–49.

Article  Google Scholar 

Amidon GL, Lennernas H, Shah VPCJ. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–20.

Article  CAS  PubMed  Google Scholar 

FDA. Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms base on a Biopharmaceutics Classification System. Maryland, EUA, 2017. 19. 2018.

Bartholomé R, Salden B, Vrolijk MF, Troost FJ, Masclee A, Bast A, et al. Paracetamol as a post prandial marker for gastric emptying, a food-drug interaction on absorption. PLoS One. 2015;10(9): e0136618.

Article  PubMed  PubMed Central  Google Scholar 

Sagara K, Mizuta H, Ohshiko M, Shibata M, Haga K. Relationship between the phasic period of interdigestive migrating contraction and the systemic bioavailability of acetaminophen in dogs. Pharm Res. 1995;12:594–8.

Article  CAS  PubMed  Google Scholar 

Chen M-L, Sadrieh N, Yu L. Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs. AAPS J. 2013;15:1043–50.

Article  PubMed  PubMed Central  Google Scholar 

Hofsäss MA, Dressman J. Evaluation of differences in dosage form performance of generics using BCS-based biowaiver specifications and biopharmaceutical modeling–case examples amoxicillin and doxycycline. J Pharm Sci. 2020;109(8):2437–53.

Article  PubMed  Google Scholar 

Suarez-Sharp S, Li M, Duan J, Shah H, Seo P. Regulatory experience with in vivo in vitro correlations (IVIVC) in new drug applications. AAPS J. 2016;18:1379–90.

Article  CAS  PubMed  Google Scholar 

FDA. GDUFA I. 2012.

FDA. GDUFA reauthorization performance goals and program enhancements fiscal years 2018-2022. 2017.

Heimbach T, Suarez-Sharp S, Kakhi M, Holmstock N, Olivares-Morales A, Pepin X, et al. Dissolution and translational modeling strategies toward establishing an in vitro-in vivo link—a workshop summary report. Springer; 2019.

Zhang X, Duan J, Kesisoglou F, Novakovic J, Amidon GL, Jamei M, et al. Mechanistic oral absorption modeling and simulation for formulation development and bioequivalence evaluation: report of an FDA public workshop. Vol. 6, CPT: Pharmacometrics & Systems Pharmacology. Wiley Online Library; 2017. 492–5.

Zhang X, Yang Y, Grimstein M, Fan J, Grillo JA, Huang S-M, et al. Application of PBPK modeling and simulation for regulatory decision making and its impact on US prescribing information: an update on the 2018–2019 submissions to the US FDA’s Office of Clinical Pharmacology. J Clin Pharmacol. 2020;60:S160–78.

Article  CAS  PubMed  Google Scholar 

Huang S-M, Abernethy DR, Wang Y, Zhao P, Zineh I. The utility of modeling and simulation in drug development and regulatory review. J Pharm Sci. 2013;102(9):2912–23.

Article  CAS  PubMed  Google Scholar 

Butler J, Hens B, Vertzoni M, Brouwers J, Berben P, Dressman J, et al. In vitro models for the prediction of in vivo performance of oral dosage forms: recent progress from partnership through the IMI OrBiTo collaboration. Eur J Pharm Biopharm. 2019;136:70–83.

Article  CAS  PubMed  Google Scholar 

Lennernas H, Lindahl A, Van Peer A, Ollier C, Flanagan T, Lionberger R, et al. In vivo predictive dissolution (IPD) and biopharmaceutical modeling and simulation: future use of modern approaches and methodologies in a regulatory context. Mol Pharm. 2017;14(4):1307–14.

Article  CAS  PubMed  Google Scholar 

Augustijns P, Vertzoni M, Reppas C, Langguth P, Lennernäs H, Abrahamsson B, et al. Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: history, methodology and applications. Eur J Pharm Sci. 2020;155: 105517.

Article  CAS  PubMed  Google Scholar 

Hens B, Sinko PD, Job N, Dean M, Al-Gousous J, Salehi N, et al. Formulation predictive dissolution (fPD) testing to advance oral drug product development: an introduction to the US FDA funded ‘21st Century BA/BE’project. Int J Pharm. 2018;548(1):120–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hens B, Tsume Y, Bermejo M, Paixao P, Koenigsknecht MJ, Baker JR, et al. Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs. Mol Pharm. 2017;14(12):4281–94.

Article  CAS  PubMed  Google Scholar 

Parrott N, Suarez-Sharp S, Kesisoglou F, Pathak SM, Good D, Wagner C, et al. Best practices in the development and validation of physiologically based biopharmaceutics modeling. A workshop summary report. J Pharm Sci. 2021;110(2):584–93.

Kuminek G, Salehi N, Waltz NM, Sperry DC, Greenwood DE, Hate SS, et al. Use of gastrointestinal simulator, mass transport analysis, and absorption simulation to investigate the impact of pH modifiers in mitigating weakly basic drugs’ performance issues related to gastric pH: palbociclib case study. Mol Pharm. 2022;20(1):147–58.

Article  PubMed  Google Scholar 

Guimarães M, Somville P, Vertzoni M, Fotaki N. Investigating the critical variables of azithromycin oral absorption using in vitro tests and PBPK modeling. J Pharm Sci. 2021;110(12):3874–88.

Article  PubMed  Google Scholar 

Kambayashi A, Dressman JB. Towards virtual bioequivalence studies for oral dosage forms containing poorly water-soluble drugs: a physiologically based biopharmaceutics modeling (PBBM) approach. J Pharm Sci. 2022;111(1):135–45.

Article  CAS  PubMed  Google Scholar 

Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res. 1991;8:360–4.

Article  CAS  PubMed  Google Scholar 

Koziolek M, Schneider F, Grimm M, Mode C, Seekamp A, Roustom T, et al. Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies. J Control release. 2015;220:71–8.

Article  CAS  PubMed  Google Scholar 

Lindahl A, Ungell A-L, Knutson L, Lennernäs H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res. 1997;14:497–502.

Article  CAS  PubMed  Google Scholar 

Zamek-Gliszczynski MJ, Lee CA, Poirier A, Bentz J, Chu X, Ellens H, et al. ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans. Clin Pharmacol & Ther. 2013;94(1):64–79.

Article  CAS  Google Scholar 

Cristofoletti R, Dressman JB. Bridging the gap between in vitro dissolution and the time course of ibuprofen-mediating pain relief. J Pharm Sci. 2016;105(12):3658–67.

Article  CAS  PubMed  Google Scholar 

Cristofoletti R, Hens B, Patel N, Esteban VV, Schmidt S, Dressman J. Integrating drug-and formulation-related properties with gastrointestinal tract variability using a product-specific particle size approach: case example ibuprofen. J Pharm Sci. 2019;108(12):3842–7.

Article  PubMed  Google Scholar 

Koenigsknecht MJ, Baker JR, Wen B, Frances A, Zhang H, Yu A, et al. In vivo dissolution and systemic absorption of immediate release ibuprofen in human gastrointestinal tract under fed and fasted conditions. Mol Pharm. 2017;14(12):4295–304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rippie EG, Lamb DJ, Romig PW. Solubilization of weakly acidic and basic drugs by aqueous solutions of polysorbate 80. J Pharm Sci. 1964;53(11):1346–8.

Article  CAS  PubMed  Google Scholar 

Jinno J, Oh D, Crison JR, Amidon GL. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J Pharm Sci. 2000;89(2):268–74.

Article  CAS  PubMed  Google Scholar 

Glomme A, März J, Dressman JB. Predicting the intestinal solubility of poorly soluble drugs. Pharmacokinet profiling drug Res Biol Physicochem Comput Strateg. 2006;259–80.

Wang J, Flanagan DR. General solution for diffusion-controlled dissolution of spherical particles. 2. Evaluation of experimental data. J Pharm Sci. 2002;91(2):534–42.

Wang J, Flanagan DR. General solution for diffusion-controlled dissolution of spherical particles. 1. Theory. J Pharm Sci. 1999;88(7):731–8.

Johnson KC. Comparison of methods for predicting dissolution and the theoretical implications of particle-size-dependent solubility. J Pharm Sci. 2012;101(2):681–9.

Article  CAS  PubMed  Google Scholar 

Chen Y, Wang J, Flanagan DR. Fundamental of diffusion and dissolution. In: Developing solid oral dosage forms. Elsevier; 2017. 253–70.

Pepin X, Goetschy M, Abrahmsén-Alami S. Mechanistic models for USP2 dissolution apparatus, including fluid hydrodynamics and sedimentation. J Pharm Sci. 2022;111(1):185–96.

Article  CAS  PubMed  Google Scholar 

Bai GE, Armenante PM, Plank RV, Gentzler M, Ford K, Harmon P. Hydrodynamic investigation of USP dissolution test apparatus II. J Pharm Sci. 2007;96(9):2327–49.

Article  CAS  PubMed  Google Scholar 

Ozturk SS, Palsson BO, Dressman JB. Dissolution of lonizable drugs in buffered and unbuffered solutions. Pharm Res. 1988;5:272–82.

Article